Clinical Trial Update: Study Comparing Trifarotene Cream, 0.005% To AKLIEF ® (Trifarotene 0.005% Cream) In The Treatment Of Acne Vulgaris [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Teva's Trifarotene Cream 0.005% with AKLIEF (trifarotene 0.005% cream) for acne vulgaris has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• AKLIEF (trifarotene)
• Trifarotene Cream 0.005% (trifarotene)

Snippet

Sponsor: Teva Pharmaceuticals USA | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED | Results posted: 2024-09-26